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Anaerobic cellulitis as the result of Clostridium
perfringens: A rare cause of vascular access graft
infection
Luc G. Y. Claeys, MD, and Ricardo Matamoros, MD, Herne, Germany
Infection of prosthetic vascular access grafts is the second most common complication of vascular access and represents a
challenge encountered by the vascular surgeon. Anaerobic graft infections are rare. We report on a case of a prosthetic
vascular access graft infection with Clostridium perfringens. To our knowledge, only one other case with an infected
arteriovenous shunt caused by C perfringens has been reported. The patient, a 67-year-old woman with end-stage renal
failure as the result of polycystic renal disease, was seen with an infected pseudoaneurysm at the arterial puncture site of
the loop graft on the left arm. There was associated purulence at the time of operation. Surgical management consisted
of complete graft removal because of the presence of small tunnel abscesses. C perfringens was found in the resected
pseudoaneurysm and graft material. Infected pseudoaneurysms most likely are attributable to repetitive punctures in one
small area and to a break in sterile technique. A compromised vascular supply, not infrequent in patients for hemodialysis,
may lower the oxidation reduction potential, which allows anaerobic bacteria, such as C perfringens, to cause infection.
(J Vasc Surg 2002;35:1287-8.)
Infection of prosthetic vascular access grafts is the sec-
ond most common complication of vascular access.1 Staph-
ylococcus aureus is the most frequent causative organism,
but other pathogens have been isolated. Infections of pros-
thetic vascular grafts, including prosthetic vascular access
grafts, with Clostridium are rare. The clinical implications,
natural history, and optimal therapy of such graft infections
are unknown.2 A Medline review disclosed one case of an
arteriovenous shunt infection as the result of Clostridium
perfringens.3 This report represents our only encounter
with clostridial infection of a vascular access graft.
CASE REPORT
A 67-year-old woman was admitted to the emergency room at
the University Hospital Herne with a bleeding complication at the
puncture site of the prosthetic vascular access graft. End-stage
renal failure was caused by polycystic renal disease, and chronic
hemodialysis had been performed since 1985. The medical history
included a cholecystectomy, and mild arterial hypertension was
shown to be in good control. The patient received a standard
polytetrafluoroethylene-loop graft from the brachial artery to the
cephalic vein of the left arm in 1994. Since that time, the patient
underwent two thrombectomies and two angioplasties for stenosis
and restenosis in the subclavian vein. Before admission to the
hospital, the loop graft functioned well for 15 months. Five weeks
before admission, the patient was seen with a painful swelling at the
arterial punction site. At admission, the patient’s condition was
afebrile, despite local signs of infection. Vital signs included a
blood pressure of 135/80 mm Hg and a pulse of 83 beats per
minute. Physical examination results were remarkable for localized
cellulitis, erythema, tenderness, skin erosion, and persistent drain-
age of blood over the punction site. The swelling impressed as a
pseudoaneurysm covered by a blood crust as the result of chronic
bleeding. Empiric treatment with vancomycin hydrochloride was
started. Preoperative blood test results were healthy except for
renal parameters.
At operation, the pseudoaneurysm was excluded and the roof
of the aneurysm was opened. A defect of 1 0.5 cm was observed
in the wall of the graft. Surgical management consisted of complete
graft removal, because infection of the graft with small tunnel
abscesses was manifest, debridement, and drainage. Samples were
taken from the aneurysm wall and graft and inoculated into vials
with aerobic and anaerobic conditions. The bacteriologic study
results revealed a mixed type of infection with low counts of
Escherichia coli and Pseudomonas aeruginosa and high counts of C
perfringens. Antibiotic treatment consisted of vancomycin hydro-
chloride for 10 days and penicillin G when aneurysm tissue and
graft cultures grew C perfringens. Penicillin G treatment was
maintained for 4 weeks. X-ray results showed no evidence of
osteitis. The postoperative course was uneventful. At discharge,
laboratory and clinical findings were healthy. Evaluation results at
2 and 6 months after discharge did not reveal any symptoms or
physical findings. Dialysis was performed with a Sheldon catheter,
and 2 months later, an autologous arteriovenous shunt of a super-
ficial femoral artery to long saphenous vein in the straight config-
uration was constructed.
DISCUSSION
Infection of prosthetic vascular access grafts is the sec-
ond most common complication of vascular access, after
thrombosis, and is responsible for 10% of all deaths in
patients for chronic hemodialysis.1 The incidence rate of
prosthetic vascular access graft infection varies from 5% to
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20%.4 Gram-positive organisms predominate in graft infec-
tions, and more than 70% of all access-related infections are
attributable to S aureus. Roughly 20% of vascular access
infections are caused by gram-negative organisms, includ-
ing Ps aeruginosa and E coli. Anaerobic infection of a
vascular graft is rare.5,6 Clostridial vascular access graft
infection is a case event. A compromised vascular supply,
not infrequent in patients for hemodialysis, has been sug-
gested to lower the oxidation-reduction potential, allowing
anaerobic bacteria to cause infection.3
Clostridia are gram-positive, anaerobic, spore-forming,
motile bacteria (family Bacillaceae) that are ubiquitous in
nature. Most of the 60 recognized species are obligate
anaerobes. However, few are aerotolerant. Clostridia are
generally found in soil and in the gastrointestinal tract of
humans and animals. Many toxigenic strains are pathogenic
to humans and include C perfringens, C septicum, C fallax,
and others. Infection associated with clostridia range from
localized wound contamination to overwhelming systemic
disease. Clinical symptoms develop when environmental
conditions are conductive to the proliferation of these
opportunists and the elaboration of the toxin.2 Despite the
isolation of clostridial species from many serious traumatic
wounds, the prevalence of severe infections caused by spe-
cies of the genus Clostridium is low. Therefore, the diag-
nosis of clostridial infection, in association with positive
cultures, must be primarly on the basis of clinical findings.7
Two main factors that appear to be essential to the
development of severe disease are tissue necrosis and a low
oxidation-reduction potential.2 C perfringens requires
about 14 amino acids and at least six additional growth
factors for optimal growth. These nutrients are present in
necrotic tissue. Furthermore, immunocompromising con-
ditions, such as in patients for chronic hemodialysis or
transplant, appear to predispose to clostridial infections.8,9
Anaerobic cellulitis is a localized infection involving the
skin and soft tissue and is caused by clostridia alone or with
other bacteria. There are no systemic signs of toxicity,
although the infection may invade locally, producing ne-
crosis. These infections tend to be relatively indolent,
spreading slowly to contiguous areas.7
In our case, the diagnostic criteria were fulfilled because
localized suppurative infection of the skin and soft tissue
was manifest and because bacteriology results revealed a
mixed type of infection with high counts of C perfringens.
The primary pathogen in this case was most likely C per-
fringens, whereas E coli and Ps aeruginosa were present as
opportunists. Although some clostridial diseases may arise
exogenously, the source of most is the patient’s own flora.
Puncture site infections in patients for hemodialysis gener-
ally are most likely attributable to a break in sterile puncture
technique, hematoma/pseudoaneurysm formation, or
other technical problems during cannulation. Infected
pseudoaneurysms are a frequent complication of vascular
access grafts and are potentially dangerous because they can
lead to life-threatening hemorrhage. Puncture site infec-
tions manifest themselves with local tenderness, swelling,
and erythema centered over the cannulation site. This type
of infection can progress to skin erosion in which the graft
is exposed without gross infection or erosions with local-
ized infection or abscess formation.1
Once access site infection has developed, prompt treat-
ment is important for any possibility of graft salvage and for
prevention of sepsis. The initial treatment is administration
of systemic antibiotics. Empiric treatment with vancomycin
hydrochloride can be started until culture and sensitivity
results return. In case of a clostridial infection, penicillin G
has excellent activity against most strains of C perfringens
and is the drug of choice for treatment of such infections.7
Graft infection with tunnel abscesses usually requires
complete graft removal and drainage to control the infec-
tion. However, consideration of graft salvage should occur
in each case of graft infection.10 In the case of an infection
as the result of clostridia, complete graft removal is manda-
tory.
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